The incidence rate of p53 gene mutations in GC tissue has been reported to be as high as 40.9%, and studies have found that GADD45B expression is inhibited in GC with p53 mutations, which may contribute to the development and progression of GC [28]. The gene discussed is TP53; the disease is gastric cancer.